The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population – Public Health Implications
Sayeeda Rahman,1 Keerti Singh,2 Sameer Dhingra,3 Jaykaran Charan,4 Paras Sharma,5 Salequl Islam,6 Dilshad Jahan,7 Katia Iskandar,8 Nandeeta Samad,9 Mainul Haque10 1School of Medicine, American University of Integrative Sciences, Bridgetown, Barbados; 2Faculty of Medical Science, The University of th...
Guardado en:
Autores principales: | Rahman S, Singh K, Dhingra S, Charan J, Sharma P, Islam S, Jahan D, Iskandar K, Samad N, Haque M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/51d2ea2e008843d28e1ce7d3f68ad4ed |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Costs of medication in older patients: before and after comprehensive geriatric assessment
por: Unutmaz GD, et al.
Publicado: (2018) -
Polypharmacy Management in the Older Adults: A Scoping Review of Available Interventions
por: M. Kurczewska-Michalak, et al.
Publicado: (2021) -
Polypharmacy in the HIV-infected older adult population
por: Gleason LJ, et al.
Publicado: (2013) -
Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community
por: Ulrich Bergler, et al.
Publicado: (2021) -
Rates, variability, and associated factors of polypharmacy in nursing home patients
por: Beloosesky Y, et al.
Publicado: (2013)